An improved sofosbuvir preparation method

A compound, Lewis acid technology, applied in the field of medicine and chemical industry, can solve problems such as unsafe

Active Publication Date: 2017-02-15
SUNSHINE LAKE PHARM CO LTD
View PDF5 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The scheme provided by the present invention does not use flammable and explosive tert-butylmagnesium chloride, has the advantages of mild reaction conditions, convenient reagent storage, safe use, easy operation, convenient post-treatment, etc., and is easy to realize large-scale production of raw materials in factories, overcoming existing problems. There are disadvantages that the method of synthesizing Sofosbuvir is not safe

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An improved sofosbuvir preparation method
  • An improved sofosbuvir preparation method
  • An improved sofosbuvir preparation method

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] Specifically, the improved sofosbuvir preparation method of the present invention may include:

[0035] a) adding compound I, compound II, Lewis acid and organic solvent into the reaction vessel, and adding alkali;

[0036] b) Control the reaction temperature of the system at 20°C to 40°C, and stir the reaction until the compound I content is ≤3.0%;

[0037] c) stop the reaction, extract the reaction solution, and then perform crystallization to obtain compound III.

[0038] Specifically, the method for preparing the improved sofosbuvir described in the present invention may include the following steps:

[0039] a) adding compound I, compound II, Lewis acid and organic solvent into the reaction vessel, and adding alkali;

[0040] b) Control the reaction temperature of the system at 20°C to 40°C, and stir the reaction until the compound I content is ≤3.0%;

[0041] c) Stop the reaction, extract the reaction solution with dichloromethane, wash with aqueous sodium carbo...

specific Embodiment approach

[0081] In order to enable those skilled in the art to better understand the technical solutions of the present invention, some non-limiting examples are further disclosed below to further describe the present invention in detail.

[0082] The reagents used in the present invention can be purchased from the market or can be prepared by the methods described in the present invention.

[0083] In the present invention, ml or mL refers to milliliter, L refers to liter, g refers to gram, kg refers to kilogram, mol / L refers to mole / liter, h refers to hour, min refers to minute, v / v refers to volume ratio,

[0084] HPLC detection chromatographic conditions are as follows:

[0085] Chromatographic column: Waters XSELECT HSS T3 (4.6*100mm, 2.5um);

[0086] Flow rate: 1.5mL / min; Detection wavelength: 210nm; Column temperature: 25°C;

[0087] Running time: 29min; Injection volume: 2μl;

[0088] Mobile phase: Phase A: Dissolve 0.5mL of ...

PUM

Abstract

Description

Claims

Application Information

Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products